Abstract
1. Studies of the regulation of neurosecretory cell gene expression suffer from the lack of suitable cell lines. Two approaches have been used to overcome this deficit: transfection of neuropeptide genes into heterologous cell lines and generation of transgenic animals.
2. Studies with heterologous cell lines have revealed the potential involvement of nuclear hormone receptors, POU proteins, and fos/jun/ATF family members in the regulation of the vasopressin and oxytocin genes. Although limited in their scope, these studies have contributed greatly to the dissection of basic properties of elements in the vasopressin and oxytocin gene promoters.
3. Transgenic mice, and more recently rats, have been used to elucidate genomic regions governing cell specificity and physiological regulation of neurosecretory gene expression. The genes encoding the neuropeptides vasopressin and oxytocin have been used in many transgenic studies, due to the well-defined expression patterns and physiology of the endogenous neuropeptides. Cell-specific and physiologically regulated expression of these transgenes has been achieved, demonstrating the action of putative represser elements and regulation of the expression of one gene by sequences present in the other gene.
4. Appropriate expression and translation of transgenes have resulted in the production of several useful systems. Expression of oncogene sequences in gonadotropin-releasing hormone neurons has allowed the development of cell lines from the resulting tumors, overproduction of corticotropin-releasing factor has produced animal models of anxiety and obesity, and directed ectopic expression of growth hormone has generated a potentially useful rat model of dwarfism. These and other animal models of human disease will provide important avenues for the development of therapeutic strategies.
Similar content being viewed by others
REFERENCES
Adan, R. A. H., and Burbach, J. P. H. (1992). Regulation of vasopressin and oxytocin gene expression by estrogen and thyroid hormones. Prog. Brain Res. 92:127–136.
Adan, R. A. H., Walther, N., Cox, J. J., Ivell, R., and Burbach, J. P. H. (1991). Comparison of the estrogen responsiveness of the rat and bovine oxytocin promoters. Biochem. Biophys. Res. Commun. 175:117–122.
Adan, R. A. H., Cox, J. J., Kats, J. P., and Burbach, J. P. H. (1992). Thyroid hormone regulates the oxytocin gene. J. Biol. Chem. 267:3771–3777.
Adan, R. A. H., Cox, J. J., Beischlag, T. V., and Burbach, J. P. H. (1993). A composite hormone response element mediates the transaction of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol. Endocrinol. 7:47–57.
Ang, H.-L., Carter, D. A., and Murphy, D. (1993). Neuron-specific expression and physiological regulation of bovine vasopressin transgenes in mice. EMBO J. 12:2397–2409.
Axelrod, J., and Reisine, T. D. (1984). Stress hormones: Their interaction and regulation. Science 224:452–459.
Axelson, J. F., and Van Leeuwen, F. W. (1990). Differential localization of estrogen receptors in various vasopressin synthesizing nuclei of rat brain. J. Neuroendocrinol. 2:209–216.
Banerjee, S. A., Roffler-Tarlov, S., Szabo, M., Frohman, L., and Chikaraishi, D. M. (1994). DNA regulatory sequences of the rat tyrosine hydroxylase gene direct correct catecholaminergic cell-type specificity of a human growth hormone reporter in the CNS of transgenic mice causing a dwarf phenotype. Mol. Brain Res. 24:89–106.
Beato, M. (1989). Gene regulation by steroid hormones. Cell 56:335–344.
Behringer, R. R., Matthews, L. S., Palmiter, R. D., and Brinster, R. L. (1988). Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev. 2:453–461.
Belenky, M., Castel, M., Young, W. S., III, Gainer, H., and Cohen, S. (1992). Ultrastructural immunolocalisation of rat oxytocin-neurophysin in transgenic mice expressing the rat oxytocin gene. Brain Res. 583:279–286.
Bradley, D. J., Young, W., III, and Weinberger, C. (1989). Differential expression of and thyroid hormone receptor genes in rat brain and pituitary. Proc. Natl. Acad. Sci. USA 86:7250–7254.
Burbach, J. P. H., and Adan, R. A. H. (1993). The rat oxytocin gene. Physiological changes in expression in the hypothalamo-neurohypophysial system and responsiveness of promoter activity. Ann. N.Y. Acad. Sci. 689:34–49.
Burbach, J. P. H., De Hoop, M. J., Schmale, H., Richter, D., De Kloet, E. R., Ten Haaf, J. A., and De Wied, D. (1984). Differential responses to osmotic stress of vasopressin-neurophysin mRNA in hypothalamic nuclei. Neuroendocrinology 39:582–584.
Burbach, J. P. H., Adan, R. A. H., Van Tol, H. H. M., Verbeeck, M. A. E., Axelson, J. F., Van Leeuwen, F. W., Beekman, J. M., and Ab, G. (1990). Regulation of the rat oxytocin gene by estradiol. J. Neuroendocrinol. 2:633–639.
Burbach, J. P. H., Lopes, Da Silva, S., Cox, J. J., Adan, R. A. H., Cooney, A. J., Tsai, M.-J., and Tsai, S. Y. (1994). Repression of estrogen-dependent stimulation of the oxytocin gene by COUP transcription factor I. J. Biol. Chem. 269:15046–15053.
Carey, R. M., Varma, S. K., Drake, C. R., Thorner, M. O., Lovacs, K., Rivier, J., and Vale, W. (1984). Ectopic secretion of corticotrophin-releasing factor as a cause of Cushing's syndrome. N. Engl. J. Med. 311:13–20.
Chambers, T. J., Owens, J. M., Hattersley, G., Jat, P. S., and Noble, M. D. (1993). Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbA58 transgenic mouse. Proc. Natl. Acad. Sci. USA 90:5578–5582.
Chang, C., Lopes Da Silva, S., Ideta, R., Lee, Y., Yeh, S., and Burbach, J. P. H. (1994). Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily. Proc. Natl. Acad. Sci. USA 91:6040–6044.
Charlton, H. M., Clark, R. G., Robinson, I. C. A. F., Goff, A. E., Cox, B. S., Bugnon, C., and Bloch, B. A. (1988). Growth hormone-deficient dwarfism in the rat: A new mutation. J. Endocrinol. 119:51–58.
Clark, R. G., Chambers, G., Lewin, J., and Robinson, I. C. A. F. (1986). Automated repetitive microsampling of blood: Growth hormone profiles in conscious male rats. J. Endocrinol. 111:27–35.
Dale, H. H. (1906). On some physiological actions of ergot. J. Physiol. 34:165–206.
Earnest, D. J., and Sladek, C. D. (1986). Circadian rhythms of vasopressins release from individual rat suprachiasmatic explants in vitro. Brain Res. 382:129–133.
Eicher, E. M., and Beamer, W. G. (1976). Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, in chromosome 6. J. Hered. 67:87–91.
Faus, I., Hsu, H. J., and Fuchs, E. (1994). Oct-6: A regulator of keratinocyte gene expression in stratified squamous epithelia. Mol. Cell. Biol. 14:3263–3275.
Fitzsimmons, M. D., Roberts, M. M., Sherman, T. G., and Robinson, A. G. (1992). Models of neurohypophyseal homeostasis. Am. J. Physiol. 262:R1121–R1130.
Fitzsimmons, M. D., Roberts, M. M., and Robinson, A. G. (1994). Control of posterior pituitary vasopressin content: Implications for the regulation of the vasopressin gene. Endocrinology 134:1874–1878.
Flavell, D. M., Wells, T., Wells, S. E., Carmignac, D. F., Thomas, G. B., and Robinson, I. C. A. F. (1995). A new dwarf rat I: Dominant negative phenotype in GRF-GH transgenic growth retarded (Tgr) rats. 77th Annual Meeting, U.S. Endocrine Society, Washington, DC, P2–239.
Flavell, D. M., Wells, T., Wells, S. E., Carmignac, D. F., Thomas, G. B., and Robinson, I. C. A. F. (1996). Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons. EMBO J. 15:3871–3879.
Fletcher, J. M. (1986). Effects of adrenalectomy before weaning in the genetically obese Zucker rat (fa/fa). Br. J. Nutr. 56:141–151.
Friemann, A. S., Fay, M. J., and North, W. G. (1995). Factors regulating the production of human vasopressin-associated neurophysin by small-cell carcinoma of the lung: Evaluation by computer-enhanced quantitative immunocytochemistry. Neuropeptides 28:183–189.
Gainer, H. (1995). Strategies for cell biological studies in oxytocinergic neurons. In Ivell, R. (ed.), Oxytocin: Cellular and Molecular Approaches in Medicine and Research, Plenum Press.
Gainer, H., and Wray, S. (1994). Cellular and molecular biology of oxytocin and vasopressin. In Knobil, E., and Neill, J. D. (eds.), The Physiology of Reproduction, 2nd ed., Raven Press, New York, pp. 1099–1129.
Gold, P. W., Goodwin, F. K., and Chrousos, G. P. (1988). Clinical and biochemical manifestations of depression. N. Engl. J. Med. 319:413–420.
Grant, F. D., Reventos, J., Gordon, J. W., Kawabata, S., Miller, M., and Majzoub, J. A. (1993). Expression of the rat arginine vasopressin gene in transgenic mice. Mol. Endocrinol. 7:659–667.
Groves, A. K., Entwistle, A., Jat, P. S., and Noble, M. (1993). The characterisation of astrocyte cell lines that display properties of glial scar tissue. Dev. Biol. 159:87–104.
Gura, T. (1995). Antisense has growing pains. Science 270:575–577.
Hammer, G. D., Fairchild-Huntress, V., and Low, M. J. (1990). Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice. Mol. Endocrinol. 4:1689–1697.
Hara, Y., Battey, J., and Gainer, H. (1990). Structure of mouse vasopressin and oxytocin genes. Mol. Brain Res. 8:319–324.
He, X., Treacy, M. N., Simmons, D. M., Ingraham, H. A., Swanson, L. W., and Rosenfeld, M. G. (1989). Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340:35–42.
He, X., Gerrero, R., Simmons, D. M., Park, R. E., Lin, C. R., Swanson, L. W., and Rosenfeld, M. G. (1991). Tst-1, a member of the POU domain gene family, binds the promoter of the gene encoding the cell surface adhesion molecule Po. Mol. Cell Biol. 11:1739–1733.
Ho, M.-Y., Carter, D. A., Ang, H.-L., and Murphy, D. (1995). Bovine oxytocin transgenes in mice. Hypothalamic expression, physiological regulation, and interactions with the vasopressin gene. J. Biol. Chem. 270:27199–27205.
Hollingshead, P. G., Martin, L., Pitts, S. L., and Stewart, T. A. (1989). A dominant phenocopy of hypopituitarism in transgenic mice resulting from central nervous system synthesis of human growth hormone. Endocrinology 125:1556–1564.
Ivell, R., and Richter, D. (1984). Structure and comparison of the oxytocin and vasopressin genes from rat. Proc. Natl. Acad. Sci. USA 81:2006–2010.
Jat, P. S., Noble, M. D., Ataliotis, P., Tanaka, Y., Yannoutsos, N., Larssen, L., and Kioussis, D. (1991). Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA 88:5096–5100.
Kendall, S. K., Saunders, T. L., Jin, L., Lloyd, R. V., Glode, L. M., Nett, T. M., Keri, R. A., Nilson, J. H., and Camper, S. A. (1991). Targeted ablation of pituitary gonadotropes in transgenic mice. Mol. Endocrinol. 5:2025–2036.
Kraner, S. D., Chong, J. A., Tsay, H.-J., and Mandel, G. (1992). Silencing the type II sodium channel gene: A model for neural-specific gene regulation. Neuron 9:37–44.
Lefebvre, D. L., Giaid, A., Bennett, H., Larivière, R., and Zingg, H. (1992). Oxytocin gene expression in rat uterus. Science 256:1553–1555.
Le Moine, C., and Young, W. S. (1992). RHS2, a POU domain-containing gene, and its expression in developing and adult rat. Proc. Natl. Acad. Sci. USA 89:3285–3289.
Li, L., Suzuki, T., Mori, N., and Greengard, P. (1993). Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene. Proc. Natl. Acad. Sci. USA 90:1460–1464.
Li, P., He, X., Gerrero, M. R., Mok, M., Aggarwal, A., and Rosenfeld, M. G. (1993). Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7:2483–2496.
Li, S., Crenshaw, E. B., Rawson, E. J., Simmons, D. M., Swanson, L. W., and Rosenfeld, M. G. (1990). Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528–533.
Liebhaber, S. A., Russell, J. E., Cash, F. E., and Eshleman, S. S. (1992). Inhibition of messenger RNA translation by antisense sequences. Gene Regul. 1:163–174.
Lipkin, S. M., Nelson, C. A., Glass, C. K., and Rosenfeld, M. G. (1992). A negative retinoic acid response element in the rat oxytocin promoter restricts transcriptional stimulation by heterologous transactivation domains. Proc. Natl. Acad. Sci. USA 89:1209–1213.
Lopes da Silva, S., and Burbach, J. P. H. (1995). The nuclear hormone receptor family in the brain: Classics and orphans. Trends Neurosci. 18:542–548.
Lopes da Silva, S., Van Horssen, A. M., Chang, C., and Burbach, J. P. H. (1995). Expression of nuclear hormone receptors in the rat supraoptic nucleus. Endocrinology 136:2276–2283.
Martinou, J.-C., Dubois-Dauphin, M., Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D., Catsicas, S., Pietra, C., and Huarte, J. (1994). Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017–1030.
Mathis, J. M., Simmons, D. M., He, X., Swanson, L. W., and Rosenfeld, M. G. (1992). Brain 4: A novel mammalian POU transcription factor exhibiting restricted brain-specific expression. EMBO J. 11:2551–2561.
Mellon, P. L., Windle, J. J., Goldsmith, P. C., Padula, C. A., Roberts, J. L., and Weiner, R. I. (1990). Immortalisation of hypothalamic GnRH neurons by genetically targeted tumourigenesis. Neuron 5:1–10.
Mohr, E., and Schmitz, E. (1991). Functional characterisation of estrogen and glucocorticoid responsive elements in the rat oxytocin gene. Mol. Brain Res. 9:293–298.
Mohr, E., Bahnsen, U., Kiessling, C., and Richter, D. (1988a). Expression of the vasopressin and oxytocin genes occurs in mutually exclusive sets of hypothalamic neurons. FEBS Lett. 242:144–148.
Mohr, E., Schmitz, E., and Richter, D. (1988b). A single rat genomic DNA fragment encodes both the oxytocin and vasopressin genes separated by 11 kilobases and oriented in opposite transcriptional directions. Biochimie 70:70–74.
Monuki, E. S., Kuhn, R., Weinmaster, B. D. T., and Lemke, G. (1990). Expression and activity of the POU transcription factor SCIP. Science 249:1300–1303.
Morgan, J. E., Beauchamp, J. R., Peckham, M., Ataliotis, P., Nat, P., Noble, M., Farmer, K., and Partridge, T. (1994). Myogenic cells derived from H-2KbtsA58 transgenic mice are conditionally immortal in vitro but differentiate normally in vivo. Dev. Biol. 162:486–498.
Mori, N., Stein, R., Sugmund, O., and Anderson, D. A. (1990). A cell type-preferred silencer element that controls the neural-specific expression of the SCG10 gene. Neuron 4:583–594.
Mori, N., Schoenherr, C., Vandenbergh, D. J., and Anderson, D. J. (1992). A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in nonneuronal cells but not in neuronal cells. Neuron 9:45–54.
Muglia, L., Jacobson, L., Dikkes, P., and Majzoub, J. A. (1995). Corticotropin-releasing hormone deficiency reveals a major fetal but not adult glucocorticoid need. Nature 373:427–432.
Nakai, S., Kawano, H., Yudate, T., Nishi, M., Kuno, J., Nagata, A., Jishage, K., Hamada, H., Fujii, H., Kawamura, K., Shiba, K., and Noda, T. (1995). The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev. 9:3109–3121.
Noble, M., Groves, A. K., Ataliotis, P., Ikram, Z., and Jat, P. S. (1995). The H-2KbtsA58 transgenic mouse: A new tool for the rapid generation of novel cell lines. Transgen. Res. 4:215–225.
Ornitz, D. M., Hammer, R. E., Messing, A., Palmiter, R. D., and Brinster, R. L. (1987). Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238:188–193.
Ott, I., and Scott, J. C. (1911). The action of infundibulin upon mammary secretion. Proc. Soc. Exp. Biol. Med. 8:48–49.
Pardy, K., Adan, R. A. H., Carter, D., Seah, V., Burbach, J. P. H., and Murphy, D. (1992). The identification of a cis-acting element involved in cyclic 3′,5′-adenosine monophosphate regulation of bovine vasopressin gene expression. J. Biol. Chem. 267:21746–21752.
Parker, M. G. (1993). Steroid and related receptors. Curr. Opin. Cell Biol. 5:499–504.
Pepin, M.-C., Pothier, F., and Barden, N. (1992a). Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol. Pharmacol. 42:991–995.
Pepin, M.-C., Pothier, F., and Barden, N. (1992b). Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725–728.
Radovick, S., Wray, S., Lee, E., Nicols, D. K., Nakayama, Y., Weintraub, B. D., Westphal, B. D., Cutler, G. B., Jr., and Wondisford, F. E. (1991). Migratory arrest of gonadotropin-releasing hormone neurons in transgenic mice. Proc. Natl. Acad. Sci. USA 88:3402–3406.
Renaud, L. P., and Bourque, C. W. (1991). Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin. Prog. Neurobiol. 36:131–169.
Richard, S., and Zingg, H. H. (1990). The human oxytocin gene promoter is regulated by estrogen. J. Biol. Chem. 265:6098–6103.
Richard, S., and Zingg, H. H. (1991). Identification of a retinoic acid response element in the human oxytocin promoter. J. Biol. Chem. 266:21428–21433.
Rivier, C., and Vale, W. (1983). Modulation of stress-induced ACTH release by corticotrophin-releasing factor, catecholamines and vasopressin. Nature 305:325–327.
Robinson, A. G. (1974). Elevation of plasma neurophysin in women on oral contraceptives. J. Clin. Invest. 54:209–212.
Robinson, A. G., Haluszczak, C., Wilkins, J. A., Huellmantel, A. B., and Watson, C. G. (1977). Physiological control of two neurophysins in humans. J. Clin. Endocrinol. Metab. 44:330–339.
Rubinstein, M., Mortrud, M., Liu, B., and Low, M. J. (1993). Rat and mouse proopiomelanocortin gene sequences target tissue-specific expression to the pituitary gland but not to the hypothalamus of transgenic mice. Neuroendocrinology 58:373–380.
Ruppert, S. D., Scherer, G., and Schutz, G. (1984). Recent gene conversion involving bovine vasopressin and oxytocin precursor genes suggested by nucleotide sequence. Nature 308:554–557.
Sausville, E., Carney, D., and Battey, J. (1985). The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J. Biol. Chem. 260:10236–10241.
Schedl, A., Larin, Z., Montoliu, L., Thies, E., Kelsey, G., Lehrach, H., and Schultz, G. (1993a). A method for the generation of YAC transgenic mice by pronuclear microinjection. Nucleic Acids Res. 21:4783–4787.
Schedl, A., Montoliu, L., Kelsey, G., and Schutz, G. (1993b). A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature 362:258–261.
Schoenherr, C. J., and Anderson, D. J. (1995). The neuron-restrictive silencer factor (NSRF): A coordinate repressor of multiple neuron-specific genes. Science 267:1360–1363.
Schonemann, M. D., Ryan, A., McEvilly, R. J., O'Connell, S. M., Arias, C. A., Kalla, K. A., Li, P., Sawchenko, P. E., and Rosenfeld, M. G. (1995). Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 9:3122–3135.
Sherman, T. G. (1996). Transcriptional regulation of the vasopressin gene. Curr. Opin. Endocrinol. Diabetes 3:178–183.
Stenzel-Poore, M. P., Cameron, V. A., Vaughan, J., Sawchenko, P. E., and Vale, W. (1992). Development of Cushing's syndrome in corticotrophin-releasing factor transgenic mice. Endocrinology 130:3378–3386.
Stenzel-Poore, M. P., Heinrichs, S. C., Rivest, S., Koob, G. F., and Vale, W. W. (1994). Overproduction of corticotrophin releasing factor in transgenic mice: A genetic model of anxiolytic behaviour. J. Neurosci. 14:2579–2584.
Suri, C., Fung, B. P., Tischler, A. S., and Chikaraishi, D. M. (1993). Catecholaminergic cell lines from the brain and adrenal glands of tyrosine-hydroxylase-SV40 T antigen transgenic mice. J. Neurosci. 13:1280–1291.
Suzuki, N., Rohdewohld, T. N., Gruss, P., and Schöler, H. R. (1990). Oct-6: A POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J. 9:3723–3732.
Swanson, L. W. (1992). Spatiotemporal patterns of transcription factor gene expression accompanying the development and plasticity of cell phenotypes in the neuroendocrine system. Prog. Brain Res. 92:97–113.
Takeuchi, T., Suzuki, H., Sakurai, S., Nogami, H., Okuma, S., and Ishikawa, H. (1990). Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: Detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction. Endocrinology 126:31–38.
Uhl, G. R., and Reppert, S. M. (1986). Suprachiasmatic nucleus vasopressin messenger RNA: Circadian variation in normal and Brattleboro rats. Science 232:390–393.
Umesono, K., Murakami, K. K., Thompson, C. C., and Evans, R. M. (1991). Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255–1266.
van Tol, H. H. M., Bolwerk, E. L. M., Liu, B., and Burbach, J. P. H. (1988). Oxytocin and vasopressin gene expression in the hypothalamo-neurohypophyseal system of the rat during the estrous cycle, pregnancy and lactation. Endocrinology 122:945–951.
Verbeeck, M. A. E., Sutanto, W., and Burbach, J. P. H. (1991). Regulation of vasopressin messenger RNA levels in the small cell lung carcinoma cell line GLC-8: Interactions between glucocorticoids and second messengers. Mol. Endocrinol. 5:796–801.
Verbeeck, M. A. E., Mummery, C. L., Feijen, A., and Burbach, J. P. H. (1992a). Survey of neuropeptide gene expression in tumor cell lines. Pathobiology 60:127–135.
Verbeeck, M. A. E., Burbach, J. P. H., Elands, J. P. M., De Leij, L. F. M. H., Buys, C. H. C. M., Carney, D. N., Bepler, G., Roebroek, A. J. M., and Van de Ven, W. J. M. (1992b). Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines. Pathobiology 60:136–142.
Wagner, R. W. (1994). Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333–335.
Waller, S. J., and Murphy, D. (1995). Expression of rat vasopressin transgenes in rats. In Saito, T., Kurokawa, K., and Yoshida, S. (eds.), Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research, Excerpta Medica Congress Series 1098, Elsevier, Amsterdam, pp. 89–98.
Waller, S. J., Ho, M.-Y., and Murphy, D. (1995). Production of transgenic rodents by microinjection of cloned DNA into fertilised one-cell eggs. In Glover, D. M., and Hames, B. D. (eds.), DNA Cloning 4: Mammalian Systems, Oxford University Press, Oxford, pp. 185–229.
Waller, S. J., Fairhall, K. M., Xu, J., Robinson, I. C. A. F., and Murphy, D. (1996). Neurohypophyseal and fluid homeostasis in transgenic rats expressing a tagged rat vasopressin prepropeptide in vasopressinergic magnocellular neurons. 137:5068–5077.
Walther, N., Wehrenberg, U., Brackmann, B., and Ivell, R. (1991). Mapping of the bovine oxytocin gene control region: Identification of binding sites for luteal nuclear proteins in the 5 non-coding region of the gene. J. Neuroendocrinol. 3:539–549.
Wegner, M., Drolet, D. W., and Rosenfeld, M. G. (1993). Regulation of JC virus by the poudomain transcription factor Tst-1: Implications for progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 90:4743–4747.
Wehrenberg, U., Ivell, R., and Walther, N. (1992). The COUP transcription factor (COUP-TF) is directly involved in the regulation of oxytocin gene expression in luteinizing bovine granulosa cells. Biochem. Biophys. Res. Commun. 189:496–503.
Wehrenberg, U., Ivell, R., Jansen, M., VonGoedecke, S., and Walther, N. (1994a). Two orphan receptors binding to a common site are involved in the regulation of the oxytocin gene in the bovine ovary. Proc. Natl. Acad. Sci. USA 91:1440–1444.
Wehrenberg, U., VonGoedecke, S., Ivell, R., and Walther, N. (1994b). The orphan receptor SF-1 binds to the COUP-like element in the promoter of the actively transcribed oxytocin gene. J. Neuroendocrinol. 6:1–4.
Wells, T., Flavell, D. M., Wells, S. E., Carmignac, D. F., and Robinson, I. C. A. F. (1995). A new dwarf rat II: GH secretion, responses to GRF and somatostatin, and growth stimulation by GRF in the GRF-GH transgenic (Tgr) rat. 77th Annual Meeting, U.S. Endocrine Society, Washington, DC, P2–240.
Wetsel, W. C., Eraly, S. A., Whyte, D. B., and Mellon, P. L. (1993). Regulation of gonadotropin-releasing hormone by protein kinase-A and-C in immortalised hypothalamic neurons. Endocrinology 132:2360–2370.
Whyte, D. B., Lawson, M. A., Belsham, D. D., Eraly, S. A., Bond, C. T., Adelman, J. P., and Mellon, P. L. (1995). A neuron-specific enhancer targets expression of the gonadotropin-releasing hormone gene to hypothalamic neurosecretory neurons. Mol. Endocrinol. 9:467–477.
Wierman, M. E., Bruder, J. M., and Kepa, J. K. (1995). Regulation of gonadotropin-releasing hormone gene expression in hypothalamic neuronal cells. Cell. Mol. Neurobiol. 15:79–88.
Windle, J. J., Weiner, R. I., and Mellon, P. L. (1990). Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol. Endocrinol. 4:597–603.
Wray, S., Kusano, K., and Gainer, H. (1991). Maintenance of LHRH and oxytocin neurons in slice explants cultured in serum-free media: effects of tetrodotoxin on gene expression. Neuroendocrinology 54:327–339.
Young, W. S., Reynolds, K., Shepard, E. A., Gainer, H., and Castel, M. (1990). Cell specific expression of the rat oxytocin gene in transgenic mice. Neuroendocrinology 2:917–925.
Zeng, Q., Carter, D. A., and Murphy, D. (1994a). Cell specific expression of a vasopressin transgene in rats. J. Neuroendocrinol. 6:469–477.
Zeng, Q., Foo, N.-C., Funkhouser, J. M., Carter, D. A., and Murphy, D. (1994b). Expression of a rat vasopressin transgene in rat testis. J. Reprod. Fert. 102.
Zingg, H. H., Lefebrve, D. L., and Almazan, G. (1986). Regulation of vasopressin gene expression in hypothalamic neurons. J. Biol. Chem. 261:12956–12959.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waller, S.J., Ratty, A., Burbach, J.P.H. et al. Transgenic and Transcriptional Studies on Neurosecretory Cell Gene Expression. Cell Mol Neurobiol 18, 149–171 (1998). https://doi.org/10.1023/A:1022512819023
Issue Date:
DOI: https://doi.org/10.1023/A:1022512819023